Ignite Creation Date:
2024-05-05 @ 10:17 PM
Last Modification Date:
2024-10-26 @ 10:16 AM
Study NCT ID:
NCT01077427
Status:
UNKNOWN
Last Update Posted:
2017-11-17
First Post:
2010-02-25
Brief Title:
Hyperthermia European Adjuvant Trial
Sponsor:
Klinikum der Universitaet Muenchen Grosshadern
Organization:
Klinikum der Universitaet Muenchen Grosshadern
Study Overview
Official Title:
A Randomized Two-armed Open Study on the Adjuvant Therapy in Patients With R0R1 Resected Pancreatic Carcinoma With Gemcitabine Plus Capecitabine Arm GC vs Gemcitabine Plus Cisplatin With Regional Hyperthermia Arm GPH
Status:
UNKNOWN
Status Verified Date:
2017-11
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
HEAT
Brief Summary:
Improvement of the clinical outcome in patients with resectable pancreatic carcinoma through an intensified adjuvant treatment with gemcitabine cisplatin and regional deep hyperthermia as compared to standard chemotherapy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| AIO-PAK-0111 | OTHER | Arbeitsgemeinschaft Internistische Onkologie AIO | None |
| 2008-004802-14 | EUDRACT_NUMBER | None | None |